SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Sepracor-Looks very promising -- Ignore unavailable to you. Want to Upgrade?


To: Biomaven who wrote (1878)3/2/1999 9:34:00 PM
From: BDR  Respond to of 10280
 
<<The oxybutynin example is a particularly hard one to interpret>>

SEPR's oxybutynin-R or -S or whatever they end up with will have to compete not with racemic oxybutynin but with Detrol which has a somewhat better side effect profile.